Wednesday - January 21, 2026
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
January 12, 2026
SANTA CLARA, California, Jan. 12 [Category: BizComputer Technology] -- NVIDIA, a designer of graphics processing units for the gaming, cryptocurrency and professional markets, issued the following news release:

* * *

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

*

News Summary:

* Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.

* NVI . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products